Search
Effective November 16, 2022, New Jersey will impose additional requirements when a ‘health care entity’ is sold or undergoes a change in control. The changes are the result of the enactment of S-315, on August 18, 2021. What You Need to Know: New Jersey enacted a statute that will impose additional...
In this engaging and useful session, Mr. Havens will use facts from recent food and beverage cases and recent instances of enforcement to provide practical takeaways to help the industry comply with applicable requirements and take defensible positions when developing food labels and product claims.
In this engaging and useful session, Mr. Havens will use facts from recent food and beverage cases and recent instances of enforcement to provide practical takeaways to help the industry comply with applicable requirements and take defensible positions when developing food labels and product claims.
In this engaging and useful session, Mr. Havens will use facts from recent food and beverage cases and recent instances of enforcement to provide practical takeaways to help the industry comply with applicable requirements and take defensible positions when developing food labels and product claims.
In this engaging and useful session, Mr. Havens will use facts from recent food and beverage cases and recent instances of enforcement to provide practical takeaways to help the industry comply with applicable requirements and take defensible positions when developing food labels and product claims.
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
In a Cannabis Business Times article, Partner Zachary Kobrin in Fort Lauderdale shared predictions for the newly legalized adult-use markets in Maryland and Missouri, as well as how the federal landscape may shift in the next year. On the topic of the SAFE Banking Act, Kobrin said it is “the most...
In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.
The panel will review recent developments in the investigation and prosecution of environmental crimes and misconduct by federal and state authorities. Specifically, the panel will discuss the implications for regulatory enforcement priorities arising from Environmental, Social, and Governance...
The CFPB Funding Is Under Constitutional Attack. Does the Bureau Survive? Francis "Trip" Riley, Co-Chair of the firm's Consumer Financial Services Litigation Practice, will participate as a speaker during an upcoming RESPRO webinar. This webinar will look at the history leading up to the Community...
Kathryn Doyle, a partner at Saul Ewing, will present during the Penn Medicine Commercialization Speaker Series. She will discuss the latest trends in Life Sciences intellectual property on November 17 from 12:00 - 1:00 p.m.
Franklin Zemel, a partner at Saul Ewing, LLP and a Certified Information Privacy Professional whose practice includes Privacy and Cybersecurity Law, will be one of a trio of presenters on November 17, 2022 at 12 p.m. EST for a cybersecurity training for all lawyers and firms. "Introduction to Cyber...
Feedback = Happy Clients Paul Malanowski, Saul Ewing LLP’s Director of Client Relations and Jennifer McGlinn, General Counsel for Eurofins to present during the ACC Greater Philadelphia’s Annual Women’s Summit. During their presentation, Paul and Jennifer will discuss the important role providing...